Search research articles
Contact Us
Filters
Showing results (151-160 of 342) with videos related to
Page
of 35
Sort By:
Rheumatology and Therapy
|
July 3, 2024
Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey
Lihi Eder, Pascal Richette, Laura C Coates, et al.
Arthritis Research & Therapy
|
August 16, 2023
Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study
Georg Schett, Warner Chen, Sheng Gao, et al.
Arthritis Research & Therapy
|
September 15, 2023
Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study
Georg Schett, Warner Chen, Sheng Gao, et al.
Arthritis Care & Research
|
September 16, 2020
Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab
Laura C Coates, Sonya Abraham, William Tillett, et al.
Rheumatology Advances in Practice
|
October 2, 2020
BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management
Helena Marzo-Ortega, Ai Lyn Tan, Dennis McGonagle, et al.
BMC Rheumatology
|
March 20, 2019
Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivity
Laura C Coates, Ana-Maria Orbai, Akimichi Morita, et al.
Rheumatology (Oxford, England)
|
September 25, 2025
PASDAS test-retest reliability in early, untreated PsA: data from the GOLMePsA clinical trial
Gabriele De Marco, Elizabeth M A Hensor, Dennis McGonagle, et al.
Annals of the Rheumatic Diseases
|
November 25, 2021
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)
Laura C Coates, Laure Gossec, Elke Theander, et al.
Dermatology (Basel, Switzerland)
|
April 19, 2023
Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey
April W Armstrong, Barbra Bohannan, Sicily Mburu, et al.
The Journal of Rheumatology
|
May 3, 2016
GRAPPA 2015 Research and Education Project Reports
Philip J Mease, Philip S Helliwell, Wolf-Henning Boehncke, et al.
Page
of 35
Search research articles
Search
Showing results (151-160 of 342) with videos related to
Sort By:
Page
of 35
Rheumatology and Therapy
|
July 3, 2024
Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey
Lihi Eder, Pascal Richette, Laura C Coates, et al.
Arthritis Research & Therapy
|
August 16, 2023
Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study
Georg Schett, Warner Chen, Sheng Gao, et al.
Arthritis Research & Therapy
|
September 15, 2023
Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study
Georg Schett, Warner Chen, Sheng Gao, et al.
Arthritis Care & Research
|
September 16, 2020
Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab
Laura C Coates, Sonya Abraham, William Tillett, et al.
Rheumatology Advances in Practice
|
October 2, 2020
BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management
Helena Marzo-Ortega, Ai Lyn Tan, Dennis McGonagle, et al.
BMC Rheumatology
|
March 20, 2019
Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivity
Laura C Coates, Ana-Maria Orbai, Akimichi Morita, et al.
Rheumatology (Oxford, England)
|
September 25, 2025
PASDAS test-retest reliability in early, untreated PsA: data from the GOLMePsA clinical trial
Gabriele De Marco, Elizabeth M A Hensor, Dennis McGonagle, et al.
Annals of the Rheumatic Diseases
|
November 25, 2021
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)
Laura C Coates, Laure Gossec, Elke Theander, et al.
Dermatology (Basel, Switzerland)
|
April 19, 2023
Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey
April W Armstrong, Barbra Bohannan, Sicily Mburu, et al.
The Journal of Rheumatology
|
May 3, 2016
GRAPPA 2015 Research and Education Project Reports
Philip J Mease, Philip S Helliwell, Wolf-Henning Boehncke, et al.
Page
of 35